Ginkgo biloba extract for essential hypertension: A systemic review

BackgroundGinkgo biloba extract (GBE), a traditional natural herbal product, is often used in the treatment of essential hypertension (EH) as complementary therapy in China and European countries.AimTo critically assess the current clinical evidence of efficacy and safety of GBE for EH.Methods7 electronic databases (Cochrane Library, PubMed, EMBASE, VIP, CBM, Wanfang data, and CNKI) were searched to identify randomized controlled trials (RCTs) of GBE for EH. Methodological quality was assessed independently using the Cochrane Handbook for Systematic Reviews of Interventions.ResultsA total of 9 RCTs with 1012 hypertensive patients were identified and reviewed. Most RCTs were of high risk of bias with flawed study design and poor methodological quality. 6 trials demonstrated potential positive effect of GBE as complementary therapy on BP reduction when compared with antihypertensive drug therapy; however, it was not associated with a statistically significant effect on both SBP and DBP reduction in 3 other trials. Despite the positive findings, there were so many methodological limitations and significant clinical heterogeneity. Most of the trials did not report adverse effects, and the safety of GBE is still uncertain.ConclusionNo confirmative conclusions on the efficacy and safety of GBE for EH could be drawn. More rigorous trials are warranted to support their clinical use.     

Diurnal Variation in Vascular Function: Role of Sleep

Although vascular function is lower in the morning than afternoon, previous studies have not assessed the influence of prior sleep on this diurnal variation. The authors employed a semiconstant routine protocol to study the contribution of prior nocturnal sleep to the previously observed impairment in vascular function in the morning. Brachial artery vascular function was assessed using the flow-mediated dilation technique (FMD) in 9 healthy, physically active males (mean?±?SD: 27?±?9 yrs of age), at 08:00 and 16:00?h following, respectively, 3.29?±?.37 and 3.24?±?.57?h prior sleep estimated using actimetry. Heart rate and systolic and diastolic blood pressures were also measured. The data of the experimental sleep condition were compared with the data of the “normal” diurnal sleep condition, in which FMD measurements were obtained from 21 healthy individuals who slept only during the night, as usual, before the morning test session. The morning-afternoon difference in FMD was 1?±?4% in the experimental sleep condition compared with 3?±?4% in the normal sleep condition (p?=?.04). This difference was explained by FMD being 3?±?3% lower in afternoon following the prior experimental sleep (p?=?.01). These data suggest that FMD is more dependent on the influence of supine sleep than the endogenous circadian timekeeper, in agreement with our previous finding that diurnal variation in FMD is influenced by exercise. These findings also raise the possibility of a lower homeostatic “set point” for vascular function following a period of sleep and in the absence of perturbing hemodynamic fluctuation. (Author correspondence: h.jones1@ljmu.ac.uk)     

银杏叶黄酮提取方法比较

比较不同溶剂提取银杏（ＧｉｎｋｇｏｂｉｌｏｂａＬ．）叶黄酮类化合物的提取效率,从成本效益角度考虑,以７０％乙醇作为提取溶剂更为有利。在分级沉淀中,黄酮含量与蛋白质含量呈正相关,在乙醇提取液中黄酮和蛋白质含量最高;蛋白质的存在有助于提高黄酮的溶解度。乙醇提取液用饱和（ＮＨ４）２ＳＯ４浓缩两次,可使醇相中的黄酮沉淀析出。根据试验结果,提出了银杏叶黄酮的优化提取方法。     

银杏内生真菌的生态分布

2004—2005年春夏秋3季,在江西省九江地区4个地点分别采集健康的银杏(Ginkgo biloba)植株,分离得到内生真菌198株,经形态学分类鉴定为6目、7科、22属。研究结果表明,银杏内生真菌的分布存在季节差异、组织部位差异、年龄差异;优势菌群的组成与数量随采样地点、分离组织部位、不同生长时期内生真菌的不同而变化。与中国其他地区的银杏植株内生真菌进行比较,结果表明,植物内生真菌的分布与地域具有一定的相关性,体现了内生真菌生态分布的多样性。     

银杏叶提取物对对乙酰氨基酚诱导的小鼠急性肝损伤的保护作用

目的：探究银杏叶提取物（GBE）对对乙酰氨基酚（APAP）诱导的小鼠急性肝损伤的保护作用及其机制。方法：30只小鼠随机分为对照组、模型组、GBE低、中、高剂量组（50,100,and 200 mg·kg^-1）,每组6只。除对照组外,剩余小鼠腹腔注射APAP （300 mg/kg）一次,随后GBE低、中、高剂量组按照相应剂量灌胃给药,治疗2 d后取材。观察各组肝脏大体情况和肝组织的病理组织学变化;取血测定各组小鼠血清中ALT、AST的活性和TNF-α、IL-6的水平;取肝检测各组肝组织中SOD、MPO的活性和GSH、MDA的含量;通过Western blot检测各组肝组织中Nrf2、HO-1蛋白的表达量。结果：与对照组相比,模型组肝脏明显肿大,病理表现差,血清中ALT、AST、TNF-α、IL-6的水平显著升高（P<0.01）,肝组织中GSH的含量和SOD的活性显著降低（P<0.01）,MDA的含量和MPO的活性显著升高（P<0.01）,Nrf2、HO-1蛋白表达明显下调（P<0.01）。与模型组相比,GBE组肝脏肿大减轻,病理表现有所改善,血清中ALT、AST、TNF-α、IL-6的水平显著降低（P<0.01）,肝组织中GSH的含量和SOD的活性显著提高（P<0.01）,MDA的含量和MPO的活性显著降低（P<0.01）,Nrf2、HO-1蛋白表达上调（P<0.05）,其中高剂量GBE组治疗效果最明显。结论：GBE可对APAP诱导的小鼠急性肝损伤具有保护作用,其作用机制可能是通过Nrf2/HO-1抗氧化途径发挥作用。     

银杏性别相关分子标记

利用RAPD技术寻找银杏(Ginkgo biloba L.)中与性别相关的分子标记。筛选了1200个10bp的随机引物,产生了8372个RAPD条带。只有S1478产生一条大小为682bp、雄性特异的分子标记,该分子标记被命名为S1478—682,出现在所有雄性植株中,而所有雌性植株都不具有该分子标记。通过在北京和沈阳种植的银杏植株的RAPD推广验证,说明该分子标记可以用来检测银杏植株的性别。     

Effects of Ginkgo biloba extract on the embryo‐fetal development in Wistar rats

BACKGROUND: Ginkgo biloba extract (GBE) is an herbal medicine used for treating neurodegenerative diseases, cerebrovascular insufficiency, peripheral arterial occlusive disease, and also vestibular disturbance. Some components of GBE have presented estrogenic effects and, in a previous study, high dosages of GBE caused intra‐uterine growth retardation in fetuses of Wistar rats treated during the fetogenesis period. METHODS: Pregnant Wistar rats were treated, through gavage, with different dosages of aqueous GBE (3.5, 7.0, and 14.0 mg/Kg/day), during the tubal transit and implantation period. Rats were killed on the 15th day of pregnancy and the following parameters were evaluated: clinical symptoms of maternal toxicity; maternal body weight; feed and water intake; maternal liver, kidney, and ovary weights; number of corpora lutea; implants per group ratio; pre‐ and post‐implantation loss per group ratio; live fetuses mean; dead fetuses percentage; fetus and placenta weight per offspring ratio; and fetal external malformation. RESULTS: No significant alteration was found for both the maternal and embryonic parameters evaluated. CONCLUSIONS: The GBE treatment in pregnant Wistar rats, during the tubal transit and implantation period, caused no toxic effect on the maternal organism and did not induce embryonic death, growth retardation, and/or fetal malformations. Birth Defects Res (Part B) 89:133–138, 2010. © 2010 Wiley‐Liss, Inc.     

HPLC法测定银杏叶征剂中决黄酮甙的含量

银杏 (ＧｉｎｋｇｏｂｉｌｏｂａＬｉｎｎ .)叶提取物 (ＧＢＥ)是银杏叶经提取、分离而得的干浸膏 ,是银杏叶制剂的主要原料。药理及临床表明 ,它能增加冠状动脉血流量 ,可用于动脉硬化及高血压所致的冠状动脉供血不全、心绞痛、心肌梗塞、脑血栓、脑血管痉挛等症[1] 。其活性成分主要是黄酮类和萜内酯[2 ] 。银杏叶黄酮类成分的测定方法 ,有紫外分光光度法和高效液相色谱法 ,因前者专属性较差 ,现多数厂家均采用后者。高效液相色谱法测定总黄酮甙的含量时 ,在对照品的使用上 ,既有单用槲皮素 (ｑｕｅｒｃｅｔｉｎ)为对照品的测定方法[3 ] ,…     

银杏叶提取物猴头菌转化前后降血糖作用的比较研究

The regulatory effects of blood glucose, lipid metabolism and free radical elimination were compared in streptozotocin-induced hyperglycemic rats among the following treatments: Ginkgo biloba leaf extract (EGB), the biotransformation of EGB by Hericium erinaceus, a cultural filtrate of H.erinaceus, and the cultural filtrate of H.erinaceus plus EGB, together with the normal control, the model control and the positive control (Metformin). The best results were obtained from the biotransformation treatment group, which could significantly reduce the levels of blood glucose and fructosamine. However, the treatment did not increase the blood insulin level. The EGB transformed products could obviously increase the serum superoxide dismutase activity and reduce the malondialdehyde level, but the reduction of malondialdehyde was not obvious as compared with that of the other treatment groups. This study provides a useful information on improving the medical properties of the herb extracts by biotransformation.     

银杏性别相关分子标记

利用RAPD技术寻找银杏(Ginkgo biloba L.)中与性别相关的分子标记.筛选了1 200个10 bp的随机引物,产生了8 372个RAPD条带.只有S1478产生一条大小为682 bp、雄性特异的分子标记,该分子标记被命名为S1478-682,出现在所有雄性植株中,而所有雌性植株都不具有该分子标记.通过在北京和沈阳种植的银杏植株的RAPD推广验证,说明该分子标记可以用来检测银杏植株的性别.     

银杏叶提取物猴头菌转化前后降血糖作用的比较研究

以正常对照组、模型对照组和阳性(二甲双胍)对照组为参照,试验比较了银杏叶提取物(EGB)、猴头菌转化EGB的产物、猴头菌发酵液、猴头菌发酵液中添加EGB对链脲佐菌素诱导的2型糖尿病模型大鼠血糖和血脂代谢的调节作用以及对自由基清除作用。结果显示:相对于其他给药组,猴头菌转化EGB的转化产物能更加显著地降低糖尿病模型大鼠的血糖和果糖胺水平,但是对胰岛素水平无显著的调节作用,与模型对照组和其他给药组相比,EGB转化产物可以显著提高超氧化物岐化酶活性;与模型对照组相比亦可显著降低丙二醛水平,但与其他给药组相比其降丙二醛作用差异不明显。本项研究对采用微生物转化法提高植物提取物药用效果提供了参考资料。     

Development of microsatellite markers in ginkgo (Ginkgo biloba L.)

Ginkgo biloba L. is one of the oldest unevolved tree species on Earth. We isolated five polymorphic microsatellite loci from G. biloba using a dual‐suppression polymerase chain reaction technique. These loci provided microsatellite markers with high polymorphism ranging from three to 13 alleles per locus. The observed and expected heterozygosities ranged from 0.667 to 0.952 and from 0.640 to 0.897, respectively. The markers will contribute to research on the conservation, genetic diversity and mating patterns of G. biloba.     

Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers

Introduction

Recent reviews showed that Ginkgo biloba extract EGb 761¹ is effective to enhance performance in patients with cognitive impairment (e.g., dementia). The aim of this study was to investigate the effects of EGb 761 on memory and the specificity of such effects on distinct memory functions in middle-aged healthy volunteers.

Methods

A total of 188 healthy subjects aged 45-56 years were randomised to receive EGb 761 (240 mg once daily) or placebo for 6 weeks. Outcome measures were the change in memory performance in a demanding standardised free recall paradigm (list of appointments) and a less demanding standardised recognition test (driving-route). Based on previous findings we predicted superiority of EGb 761 in recall testing. Specificity in effects was assessed by separating immediate vs. delayed and quantitative vs. qualitative free recall measures.

Results

After 6 weeks, EGb 761-treated subjects improved significantly in quantity of recall, i.e., the number of correctly recalled appointments (drug-placebo differences: p = 0.038 for immediate and p = 0.008 for delayed recall). Effects on qualitative recall performance (ratio of false to correct items) were similar (drug-placebo differences: p = 0.092 for immediate and p = 0.010 for delayed recall). No superiority of Ginkgo was evident in another everyday memory test which asked for recognition of a driving route (drug-placebo differences: p > 0.10). The incidence of adverse events was low and not significantly different between treatment groups.

Discussion

EGb 761 (240 mg once daily) improves free recall of appointments in middle-aged healthy volunteers, which requires high demands on self-initiated retrieval of learned material. This function is known to be sensitive to normal aging, i.e., reduced in healthy middle-aged subjects. No effects are seen in a less demanding everyday memory task which does not tap this critical function. This ties in with previous studies which found specific patterns of benefit from EGb 761 in demanding cognitive tasks.     

Cytoskeleton in Pollen and Pollen Tubes of Ginkgo biloba L.

The distribution of F-actin and microtubules was investigated in pollen and pollen tubes of Ginkgo biloba L. using a confocal laser scanning microscope after fluorescence and immunofluorescence labeling. A dense F-actin network was found in hydrated Ginkgo pollen. When Ginkgo pollen was germinating,F-actin mesh was found under the plasma membrane from which the pollen tube would emerge. After pollen germination, F-actin bundles were distributed axially in long pollen tubes of G. biloba. Thick F-actin bundles and network were found in the tip of the Ginkgo pollen tube, which is opposite to the results reported for the pollen tubes of some angiosperms and conifers. In addition, a few circular F-actin bundles were found in Ginkgo pollen tubes. Using immunofluorescence labeling, a dense microtubule network was found in hydrated Ginkgo pollen under confocal microscope. In the Ginkgo pollen tube, the microtubules were distributed along the longitudinal axis and extended to the tip. These results suggest that the cytoskeleton may have an essential role in the germination of Ginkgo pollen and tube growth.     

银杏雌株染色体Ag-NOR的研究

本文以银杏雌株的幼小胚珠为材料,对其体细胞染色体进行了Ag-NOR染色研究。发现其Ag-NOR(随体)的数目均为4个,大小则有同形和异形两种类型。认为NOR(随体)的数目和形态不能作为性染色体的识别特征,并对NOR的杂合性和多态性进行了讨论。 Abstract:In this paper,the Ag-NOR of somatic chromosomes of young ovulum in Ginkgo biloba was studied.It was found that the number of Ag-NORs(satellite)were four constantly,though there were two kinds in size,homoeotype and heterotype.So we considered that the number and morphology of NOR(satellite)can not be used as identification markers of sex chromosome in Ginkgo biloba.In addition,the heterozygosity and polymorphism of NOR are discussed.     

银杏雌雄配子体发育及胚胎形成的研究进展

银杏（Ginkgo biloba）是现存最古老的裸子植物之一, 其生殖过程表现出许多原始特征和独特性状, 长期以来备受国内外专家的关注。经过近100年的研究取得了显著成果： （1） 银杏雄配子体发育周期长, 经历了从平周分裂到斜背式分裂,并最终垂周分裂形成带有鞭毛的游动精子; （2） 银杏雌配子体发育经历较长的游离核期和细胞化期, 分化形成颈卵器母细胞并经平周分裂、垂周分裂和斜向分裂形成成熟的颈卵器（包括有4个颈细胞和1个卵细胞）; （3） 推测其精细胞中的液泡状结构为受精过程中的遗传物质载体; （4） 原胚的形成经历了游离核期和细胞化期。该文针对国内外最新银杏生殖生物学方面的研究进展, 对银杏雌雄配子体发育、受精过程以及胚胎形成等方面进行较为系统全面的分析和总结, 为进一步的银杏生殖生物学研究提供有价值的参考资料。     

银杏胚珠发育进程的解剖学研究

以15 a生银杏(Ginkgo bilobaL.)品种‘佛指’(G.bilobacv.‘Fozhi’)为材料,观察了授粉后胚珠结构、雌配子体发育和种皮分化形成的过程。结果表明:(1)授粉后2 d胚珠已分化出珠心、珠被和珠托组织,珠被顶端形成直径为162.16μm的珠孔与540.54μm长的珠孔道,珠心组织顶端形成长约520.83μm、最大直径约125.06μm的瓶状贮粉室,花粉粒经珠孔道已到达贮粉室并在其中停留;(2)雌配子体的发育先后经历了游离核阶段(授粉后5~30 d)和细胞化阶段(授粉后30~45 d),之后在近珠孔端形成颈卵器,其余部分发育为胚乳薄壁细胞,其营养物质的积累高峰期为授粉后60~80 d;(3)种皮分化与形成分别经历珠被分化期(授粉期至授粉后30 d)、种皮分化期(授粉后30~50 d)、种皮形成初期(授粉后50~80 d)、种皮形成期(授粉后80~90 d)。     

银杏种子和叶的蛋白质分析

采用分级提最方法提取银杏（Ginkgo biloba L.）种子和银杏叶蛋白质,并进行各组分蛋白质含量测定和银杏种子后熟过程中蛋白质含量动态变化的分析。结果表明,银杏种子以水溶性和盐溶性蛋白质为主,银杏叶以醇溶性蛋白质为主。银杏叶中主要蛋白质在HPLC柱中的保留时间为3.457min,相对含量达70%以上。银杏叶蛋白质含有丰富的亮氨酸、缬氨酸、赖氨酸和色氨酸,其含量分别为20.23%、13.35%、4.81%和3.73%。萌发种子胚体中的蛋白质主要是醇溶性蛋白质和谷蛋白类蛋白质。在种子萌发过程中,胚乳蛋白质含量明显增加,播种后第3周和萌发时总蛋白质含量达到高峰。     

银杏套细胞发育的解剖学研究

银杏套细胞起源于近雄配子体表达的颈卵器母细胞周围细胞,中央细胞形成时,套细胞呈明显的一层,围绕颈卵器紧密排列,随着颈卵器的发育,套细胞体积逐渐地大,细胞质变浓厚,细胞质中脂滴增多,套细胞和中央细胞的接触壁开始出现局部加厚,在颈卵器发育的泡沫化阶段,套细胞和中央细胞的接触壁不均匀加厚较为显著,在较薄的区域可见胞间连丝,受精前,套细胞中液泡增多,脂滴迅速减少,造淀粉体增大,套细胞与卵细胞的接触壁的不均匀加厚非常明显,精核进入颈卵器以后,卵细胞与套细胞的接触壁和卵细胞的质膜之间形成一个薄厚不均的间隔层,受精卵分裂时,受精卵细胞与套细胞接触壁的凹陷处可见许多小泡和内质网,游离核期时,套细胞内出现大量小液泡,细胞内含物迅速消失,套细胞外形变长,胚胎长出颈卵器后,套细胞逐渐解体消失。     

银杏传粉生物学研究进展

银杏(Ginkgo biloba L.)是最古老裸子植物之一,其传粉受精过程表现出许多特殊的原始性状和特征,在种子植物的系统演化上具有重要研究价值;同时,银杏种实经济价值高,但栽培上由于授粉受精不良而导致落花落果现象严重,因此了解银杏传粉生物学特性对于其种实的优质高产具有实际意义.本文从银杏雌雄株开花物候学、雌雄花形态结构特征、花粉和胚珠发育进程、花粉和胚珠生物学特性、传粉机制及花粉在胚珠内萌发生长进程等方面,对银杏传粉生物学相关研究进行综述,为银杏的系统演化、授粉受精和种实发育研究提供参考.